Loading...
•
Dec 31, 2023
Kenvue Q4 2023 Earnings Report
Kenvue's Q4 2023 results were announced, with net sales decreasing by (2.7)% and diluted earnings per share at $0.17.
Key Takeaways
Kenvue reported a decrease in net sales by (2.7)% to $3.7 billion with organic growth declining by (2.4)% in Q4 2023. Diluted earnings per share stood at $0.17, while adjusted diluted earnings per share was $0.31.
Net sales decreased by (2.7)% to $3.7 billion with organic growth declining by (2.4)%.
Diluted earnings per share was $0.17; adjusted diluted earnings per share was $0.31.
Gross profit margin increased to 55.7% compared to 54.3% in the prior year period.
Adjusted operating income margin was 21.8% versus 19.9% in the prior year period.
Kenvue
Kenvue
Kenvue Revenue by Segment
Revenue by Segment
Self Care Revenue
CapyFin.comSkin Health and Beauty Revenue
CapyFin.comEssential Health Revenue
CapyFin.com Forward Guidance
Kenvue expects full year 2024 reported Net sales growth to be in the range of 1.0%to 3.0%.
Positive Outlook
- Net sales growth to be in the range of 1.0%to 3.0%.
- Foreign exchange is expected to be a headwind of approximately one percentage point to reported Net sales growth.
- Organic growth in the range of 2.0% to 4.0% with Organic growth sequentially improving as the year progresses as prior year comparisons ease
- Impact of 2024 strategic priorities take hold
- Adjusted diluted earnings per share to be in the range of $1.10 - $1.20.
Challenges Ahead
- Potential for a continued challenging macro-back drop
- Possibility for unknowns in seasonal businesses
- Adjusted operating income margin to be slightly below 2023
- Impact of absorbing a full year of public company costs
- 50 basis points of foreign currency headwinds
Revenue & Expenses
Visualization of income flow from segment revenue to net income